JP2004018522A - Disease preventive and therapeutic formulation comprising sea mineral and lactobacillus symbiotic culture extract - Google Patents

Disease preventive and therapeutic formulation comprising sea mineral and lactobacillus symbiotic culture extract Download PDF

Info

Publication number
JP2004018522A
JP2004018522A JP2002213145A JP2002213145A JP2004018522A JP 2004018522 A JP2004018522 A JP 2004018522A JP 2002213145 A JP2002213145 A JP 2002213145A JP 2002213145 A JP2002213145 A JP 2002213145A JP 2004018522 A JP2004018522 A JP 2004018522A
Authority
JP
Japan
Prior art keywords
lactobacillus
lactic acid
minerals
acid bacteria
marine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002213145A
Other languages
Japanese (ja)
Inventor
Ichiro Ito
伊藤 一郎
Masayo Nakaya
仲谷 満佐代
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2002213145A priority Critical patent/JP2004018522A/en
Publication of JP2004018522A publication Critical patent/JP2004018522A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a disease preventive and therapeutic formulation comprising sea minerals and a lactobacillus symbiotic culture extract and having digestive function improved with a symbiotic culture extract so as to effectively ingest the sea minerals. <P>SOLUTION: The disease preventive and therapeutic formulation is obtained by adding the lactobacillus symbiotic culture extract to the sea minerals containing essential microelements, wherein the lactobacillus symbiotic culture extract is obtained by cultivating lactobacillus and yeast and the sea minerals are obtained by concentrating seawater and removing unwanted components. <P>COPYRIGHT: (C)2004,JPO

Description

【0001】
【産業上の利用分野】
本発明は海洋ミネラルを主成分とした、疾病予防及び治療組成物に関する。更に詳しくは、海洋ミネラルに少なくとも1種以上の乳酸菌と酵母を培養して得られる乳酸菌共棲培養エキスを加えた疾病予防及び治療組成物に関する。
【0002】
【従来の技術】
近年の医療技術の進歩は著しいものがあり、食物の健康に及ぼす働きが細胞レベルで解析されるように成った。特にタンパク質、炭水化物、脂質等の細胞を維持する主要栄養素であるのに対し、ビタミン類やアミノ酸類、核酸類、繊維質、及びミネラル類等が疾病を予防し体調を整える重要な成分で有る事が解って来た。
【0003】ナトリウム、カリウム、マグネシウム、カルシウム等のアルカリ金属や亜鉛、鉄、セレン、リン、鉄、クロム等の重金属を適度に摂取する事が体力の低下、視力の減退、精力減退などの老化現象や悪性腫瘍、糖尿病、高血圧症等の成人性疾患、更にアトピー性皮膚炎などアレルギー疾患の予防や症状の改善する。
【0004】各種のミネラルの不足と体の異常の具体例を挙げると
カルシウムの不足  悪性腫瘍 糖尿病 骨折 アレルギー
マグネシウムの不足 動脈硬化 心臓病 皮膚病
カリウムの不足   動脈硬化 アレルギー
鉄の不足      貧血
銅の不足      胃腸障害 心臓病 脱毛 発育不全
亜鉛の不足     悪性腫瘍 糖尿病 脱毛 虚弱 自閉症
マンガンの不足   動脈硬化 糖尿病 精力減退
クロムの不足    糖尿病
ヨードの不足    自閉症
モリブデンの不足  悪性腫瘍
セレンの不足    悪性腫瘍 白髪 精力減退 アレルギー
コバルトの不足   貧血 などがある。
【0005】循環器、消化器、呼吸器、免疫性疾患、アレルギー等多くの疾病の主な発生原因は、加齢、ストレス、化学物質等に因って体内に生じる過酸化物が関係しているとされる。
【0006】元来、生体機能の一つとして過剰の過酸化物は、体内で分泌される過酸化物消去酵素(スーパーオキサイドジスムターゼ)の働きにより消去されている。然しながら地球環境の悪化や食生活の不健性等が過酸化物の発生を助長している。
【0007】各種のミネラルをバランス良く摂取する事は、体内細胞を活性化し上記の過酸化物の発生を押えたり、直接作用して消去酵素と同様な効果を示す事が知られている。従ってミネラルの摂取が不十分であったり、吸収が阻害されてミネラルが不足すると多くの疾病が発生する。その事から高齢者が積極的にミネラルを食物以外から摂取する事は、成人病等の疾病を予防、改善する。
【0008】近年これらの摂取ミネラル源として、深海から汲み上げた海水を濃縮もしくは乾燥固体化した複合ミネラル(以下海洋ミネラルと表示)の技術と効果が報告されている。例えば『実験糖尿病マウスに対する海水ミネラルの効果』日本医事新報NO,3675(平成6年10月)、『海洋ミネラル成分からなる治療及び/または予防剤』特許公報第3247620号、『海洋ミネラル分含有水の製造法』特開2001−310192号が挙げられる。
【0009】本発明者は、長年海洋ミネラルの効果につき研究し上記の技術についても検証してきた。その結果海洋ミネラルは、ミネラル成分のバランスや経済的視野から見て、ミネラルの摂取源として極めて有効である事がわかった。
【0010】ところが本発明者は多くのテストを繰り返す中で、海洋ミネラル摂取者のおよそ40%の人が、下痢や便秘症等の消化機能に変調をきたすことがわかった。従って更に海洋ミネラルを安全で安価なミネラル源として提供する為に、消化機能に支障をきたさない海洋ミネラルを開発する事が急務であった。
【0011】
【発明が解決しようとする課題】
本発明は海洋ミネラルを主成分とした新規な組成物を提供することにある。さらに説明すれば、海洋ミネラルが消化機能に支障をきたさず、効果、効率性の高い新規な海洋ミネラル組成物を提供する事にある。
【0012】
【課題を解決するための手段】
本発明者は天然のミネラル、特に不用な不純物を含まない深い海中の海水を濃縮精製して得られる海洋ミネラルの効果を長年研究して本発明を成すに至った。本発明の改良された海洋ミネラルは、少なくとも1種以上の乳酸菌と及び1種以上の酵母菌とを共棲培養して得られる共棲培養エキス(以下乳酸菌共棲培養エキスと表示)との組み合わせにより達成される。
【0013】本発明の海洋ミネラルにつき詳細に説明する。近年心臓病、糖尿病、悪性腫瘍などの成人病の発生率が増加している。その背景には、加工食品の多用と水産物の摂取不足等の偏った食生活がある。又農業の効率化を進めるあまり、化学肥料や農薬を多用して土壌から本来植物が吸収すべき栄養素が摂取出来ない状態がある。この事が偏った栄養の摂取、特にミネラル分の慢性的欠乏となり、生体のバランスを崩す原因と成っている。
【0014】海水は全ての生物は海より発生している事からも分かるように、全てのミネラルがバランス良く含まれていて、人間の体液組成に極めて近いとされる。即ち海水、特に環境汚染の無い深海水からミネラルを取り、不足するミネラル分として摂取することは、極めて理に適った事といえる。
【0015】従って本発明に於ける海洋ミネラルとは、少なくとも海面下100m以上、好ましくは250m以下から汲み上げられ、更に過剰のナトリウムイオンや有機水銀やカドミウム化合物を除去し濃縮乾固して得られる。
【0016】本発明に関わる海洋ミネラルについては、特許第3247620号公報等に記載される方法によって製造される。即ち汲み上げた海水より濃縮操作により体積容量として1/60程度にし食塩を除く。更にこの濃縮液に対して99%酢酸と0.5重量%の木炭を入れ、加圧密封下400℃に加熱し、更に−12℃まで冷却する。この操作で水銀等の有害金属が析出する。ろ過操作により固形物を除去し、得られたろ液につき同様な過熱冷却処理を繰り返して、ろ液を濃縮乾固し目的の固形粉末状の海洋ミネラルを製造する。尚この製造方法は一例として記載したもので、本発明はこれに何等限定されるもではない。
【0017】この様にして得られる海洋ミネラル1gはおよそ海水10Lからえられる。公示されている海洋ミネラル1gの組成はおよそ下記のようである。
水分     242,700μg
ナトリウム   54,300μg
カリウム    81,600μg
カルシウム  310,600μg
マグネシウム   1,700μg
有機物    253,400μg
塩素      35,300μg
珪素         125μg
鉄          125μg
銅            8μg
クロム        250μg
マンガン        10μg
亜鉛          60μg
セレン         16μg
カドミウム       検出せず
鉛           検出せず
有機水銀        検出せず
【0018】本発明に関わる乳酸菌共棲培養エキスは、複数種の乳酸菌と酵母を、主として穀物を栄養栄養分として繁殖培養させ製造される生成エキスを指す。
【0019】人間の消化器官、特に腸内には100種以上の腸内微生物が100兆個以上が生息している。腸内菌としては、ビヒズス菌、アシドフィルス等の数十種の有用菌が知られている。
【0020】これらの有用菌の主な働きとしては、消化吸収を助けたりビタミンやタンパク質及びホルモンの合成、病原菌の繁殖を抑え便通を整えたりする。
【0021】一方腸内には、腸内腐敗の原因に成ったり、有害物質(インドール、スカトール、ニトロソアミン、硫化水素、アンモニア等)や有害毒素を作る有害菌も生息する。
【0022】有害菌の例としては、ウエルシ菌類、大腸菌類、緑濃菌類、ベヨネラ菌類、ブドウ球菌類、プロテウス菌類を挙げる事が出来る。
【0023】人間の腸内に於いては、説明した有用菌と有害菌がバランスを保って繁殖していてお互いに分泌物を出して自らの繁殖の環境を維持している。従って腸内に有用菌が増殖し易い環境にするか、有用菌を別途補えば好ましい体調を維持出来る事は容易に理解される。
【0024】乳酸菌等の有用菌は、一般に経口摂取が難しい事が知られている。なぜなら乳酸菌等は、胃を通過する際低PH域で死滅するからである。
【0025】一方乳酸菌等の有用菌が生産する生成物は、死滅したり、分解したりしない事から容易に腸内に到達して有用菌の増殖を促す事が出来る。
【0026】本発明者は長年の研究において、この乳酸菌類に酵母菌を加え穀物培養された生成エキスと前記の海洋ミネラルの組み合わせ組成物が効率的かつ消化器官に影響せずミネラルの摂取がされる事を見出した。
【0027】本発明に関わる乳酸菌共棲培養エキスにつき更に説明する。乳酸菌共棲培養エキスについては多くの技術が報告され、又特許の出願もされている。例えば特開平9−132533号公報『乳酸菌発酵物からなる潰瘍抑制効果と肝臓障害抑制剤』、特開平9−289890号公報『乳酸菌乾燥粉末の製造方法』、特開平10−210947号公報、『乳酸菌含有豆腐、乳酸菌含有豆乳及び豆乳発酵物並びにそれらの製造方法』、特開平11−56302号公報『ある種のオリゴ糖と乳酸菌代謝産物による健康食品への添加利用』、特許第2904879号公報『低温感受性乳酸菌変異株、並びに其れを用いて製造する植物発酵物およびその製造法』、特開2000−300211号公報『乳酸菌代謝生産物質配合健康食品組成物』、特開2001−224330号公報『乳酸菌共棲培養物と薬用植物とからなる食品及びその製造法』、等を挙げることが出来、これらの技術は何れも本発明の構成と異なるが、当技術を達成するため応用する事が出来る。
【0028】本発明により使用される乳酸機の例としては、ストレプトコッカス・サーモフィルス、ストレプトコッカス・クレモリス、スプレプトコッカス・フェカーリス、スプレプトコッカス・ラクティス、スプレプトコッカス・ブルガリカス、ラクトバチルス・アンドフィルス、ラクトバチルス・カゼイ、ラクトバチルス・テルブルツキイ、ラクトバチルス・アラビノース、ラクトバチルス・カウカチクス、ラクトバチルス・ラクティス、ラクトバチルス・ライシュマニ、ラクトバチルス・ムシカス、ラクトバチルス・サーモフィルス、ラクトバチルス・ブランタルム、ラクトバチルス・ベントアセチクス、ラクトバチルス・ユークリティー、ラクトバチルス・ブルガリクス、ロイコノストック・メゼンデロイテス、ラクトバチルス・アシドフィルス、ラクトバチルス・ヘリベチカス、ラクトバチルス・ファーメンタム、ラクトバチルス・ビフィダム、ラクトバチルス・ベントアセチクス、ラクトバチルス・ユークリティー、ラクトバチルス・ブルガリカス、ラクトバチカル・コールンヘン、ミクロコッカス・ラクテス等を挙げる事が出来る。好ましくは5種類以上のラクトバチルス菌類を使用する事が好ましい。
【0029】本発明により使用される酵母菌の例としては、サッカロマイセス・セリビジェー、サッカロマイセス・バストリアヌス、サッカロマイセス・インタメヂウス、サッカロマイセス・バリドウス、サッカロマイセス・エリプシデウス、サッカロマイセス・マリリスラ、サッカロマイセス・マンシュリカス、サッカロマイセス・フォルチマニ、サッカロマイセス・ベーカ、サッカロマイセス・シアリング、サッカロマイセス・ビリフォルミス、サッカロマイセス・アナメンシス、サッカロマイセス・カルテラギノス、サッカロマイセス・アワモリ、サッカロマイセス・バタタエ、サッカロマイセス・コレアヌス、サッカロマイセス・ロブストウス、サッカロマイセス・モナセンシス、サッカロマイセス・アルキシアナス、サッカロマイセス・ラクテス、サッカロマイセス・マヨール、サッカロマイセス・ルクシー等のサッカロマイセス酵母類を挙げることが出来る。好ましくはこのサッカロマイセス酵母菌の相性の良い2種類以上を使用する事が好ましい。
【0030】上記の乳酸菌及び酵母菌を共棲培養させる培地養分としてては、植物類として、きゅうり、大根、ニンジン、トマト、蕪、白菜、キャベツ等の野菜類、ジャガイモ、里芋、サツマイモ、長芋等のイモ類、米、麦、稗、粟、ゴマ、コーン等の穀類、大豆、小豆、インゲン、ソラマメ等の豆類、リンゴ、梨、柿、バナナ、スイカ、桃、ウメ、イチゴ、ブドウ等の果実類、さんま、いわし、あじ、さば、いか、蜆、あさり等の魚貝類、天草、昆布、アオサ、青海苔等の海草類、牛、馬、豚、鳥、羊、ウサギ等の動物の肉及び乳を加工して使用できる。特に好ましい培地養分は穀類を挙げることが出来る。更に好ましくは、豆類とキャベツ等の繊維質に富む野菜類の組み合わせである。
【0031】本発明に関わる乳酸菌共棲培養エキスの製造方法の一例を示す。但しこの例は本発明を限定するものではない。
【0032】
(1)種母の調整
白米等の穀類及びサツマイモ等のイモ類50対50重量の物を粉砕し、必要であれば水を加えて固形分が25%になるように調整した後、攪拌機で良く混ぜ合わせる。この穀類/イモ類スラリーに10重量%分のウコン粉末を加え、任意の4種類から成る乳酸菌類と2種類の酵母類を加え攪拌機で30分間攪拌した後室温で2乃至3週間放置する。液温が35℃から40℃に一旦上昇し、再度室温まで下がった発酵済み穀類/イモ類スラリーに3倍量の冷水を加え、10℃以下の低温室で2日間静置してその上澄みを漉し取る。得られたやや混濁した液を攪拌しながら70℃30分間加熱し、その後冷蔵庫に保存して乳酸菌種母とする。
(2)培養エキスの調整
大豆5Kgを水でよく洗浄し、一昼夜静置して十分に含水させた。此れに乳酸菌種母/水が1/3とした液20Lを加える。次に此れをミキサーにかけてペースト状にする。この乳酸菌を含む大豆ペーストをオートクレイブ中で105℃15分間加熱して雑菌類を殺菌する。この殺菌済み大豆を35℃までに冷却し24時間乳酸発酵させた。更に此れを8℃以下に保った室温に密封状態で3ヶ月静置して低温発酵を続ける。発酵終了後、カーボン濾過器で固形物を除き更にオートクレイブで121℃20分間加熱して全ての微生物を滅菌処理して乳酸菌共棲培養エキスを得る。
【0033】得られた乳酸菌共棲培養エキスの100gあたりの主な成分を次ぎに示す。
ナトリウム     23.8mg
カリウム     130.8mg
カルシウム     25.0mg
マグネシウム    31.4mg
鉄          0.5mg
塩素        50.2mg
亜鉛       443  μg
マンガン     158  μg
銅         17  μg
イオウ       20.3mg
ビタミン類     50  μg
アミノ酸類     25.7mg
【0034】本発明の乳酸菌共棲培養エキスは、液状、濃縮した半液状、液を噴霧乾燥させた粉体状、更に賦形剤を使用して顆粒状や錠剤状にして供することが出来る。本発明に於いては、粉体状若しくは顆粒状にする事が好ましい。
【0035】本発明における最も好ましい形態は、分岐デキストリン若しくはアミロースによって、乳酸菌共棲培養エキスを包接したものは更に好ましい。
【0036】本発明に於ける乳酸菌共棲培養エキス成分と分岐デキストリン若しくはアミロースの包接は、培養エキスに等量の分岐サイクロデキストリン(例えばインエリートP:日研化学株式会社製)を添加し、60分間攪拌後噴霧乾燥して製造出来る。
【0037】本発明の海洋ミネラルと乳酸菌共棲培養エキス、好ましくは固形海洋ミネラルと固形乳酸菌共棲培養エキス分は、両者を簡単に混合しただけで使用できる。又両者を混合した後に賦形剤、結合剤、崩壊剤、固結防止剤、滑剤、コウティング剤等を適当に使用して一体化してもよい。
【0038】本発明に於ける固形海洋ミネラルと乳酸菌共棲培養エキスの量比は特に限定されない。特に好ましい比率は海洋ミネラル1重量部に対して乳酸器共棲培養エキスが0.1から10重量部の範囲である。
【0039】
【実施例】
以下に本発明の効果を実施例として更に詳細に説明するが、本発明がこれによって制約を受けるものではない。
【0040】
【実施例1】海洋ミネラル(株式会社海洋科学研究所製)100g当りに包接加工した乳酸菌共棲培養エキス(ワイドプランニング株式会社)を0g、25g、50g、100g、200gを乳鉢で良く混合して5水準の海洋ミネラル/乳酸菌共棲培養エキス複合物を調整した。任意に健康な50歳代の女性75人を5グループに分け、各15人毎に用意した5種類の乳酸菌共棲培養エキス含有量の異なる海洋ミネラル/乳酸菌共棲培養エキスを、1日当り海洋ミネラル成分として1.5gに成るよう3回に分けて服用した。服用を7日間続けて下痢、便秘の状況を調べて以下の結果を得た。

Figure 2004018522
本発明による海洋ミネラルと乳酸菌共棲培養エキスの併用は、海洋ミネラルの服用によって発生する下痢若しくは便秘症状の軽減に極めて有効である事がわかる。
【0041】
【実施例2】高血圧症であって、海洋ネラルを服用することにより症状の改善が見られ、且つ下痢か便秘症状のある40歳から70歳までの人30名に乳酸菌共棲培養エキス分100%の海洋ミネラルを、1日当り海洋ミネラル分として1.5gを3回に分けて服用させた。1ヶ月経過後更に7日間服用を続け下痢及び便秘の症状とその間の最高血圧を測定した。
結果1
下痢又は便秘が改善された人       25名
下痢又は便秘に変化が無かった人      3名
下痢又は便秘が悪く成った人        2名
結果2
最高血圧が10mmHg以上下がった人  18名
最高血圧が特に変化しなかった人     12名
最高血圧が10mmHg以上上がった人   0名
海洋ミネラルに乳酸菌共棲培養エキスを併用すると、下痢若しくは便秘症状が改善され、更に海洋ミネラルの機能効果も助長される事がわかる。
【0042】
【発明の効果】海洋ミネラルと乳酸菌共棲培養エキスを併用して服用する事により、海洋ミネラルによって生じる下痢や便秘等の消化不良症、状を軽減し、更に海洋ミネラルの機能効果を増す事が出来る。[0001]
[Industrial application fields]
The present invention relates to a disease prevention and treatment composition based on marine minerals. More specifically, the present invention relates to a disease prevention and treatment composition obtained by adding a lactic acid bacteria co-cultivated extract obtained by culturing at least one kind of lactic acid bacteria and yeast to marine minerals.
[0002]
[Prior art]
Recent advances in medical technology have been remarkable, and the effects on food health have been analyzed at the cellular level. In particular, vitamins, amino acids, nucleic acids, fibers, minerals, etc. are important ingredients that prevent diseases and improve physical condition, while they are macronutrients that maintain cells such as proteins, carbohydrates, and lipids. Came to understand.
Aging phenomena such as decreased physical fitness, decreased visual acuity, decreased vitality, etc. by appropriately taking in alkali metals such as sodium, potassium, magnesium and calcium and heavy metals such as zinc, iron, selenium, phosphorus, iron and chromium Prevent malignant tumors, diabetes, hypertension and other adult diseases, and allergic diseases such as atopic dermatitis and improve symptoms.
Specific examples of various mineral deficiencies and abnormalities of the body Calcium deficiency Malignant tumor Diabetes Fracture Lack of allergic magnesium Atherosclerosis Heart disease Deficiency of potassium for skin disease Arteriosclerosis Lack of allergic iron Lack of anemia copper Gastrointestinal disorders Heart disease hair loss growth deficiency zinc deficiency malignant tumor diabetes hair loss weakness autism manganese deficiency arteriosclerosis diabetes deficiency of chromium deficiency diabetic iodine deficiency autism molybdenum deficiency malignant tumor selenium deficiency malignant tumor gray hair loss of vigor allergy cobalt Insufficient anemia.
The main causes of many diseases such as circulatory organs, digestive organs, respiratory organs, immune diseases, and allergies are related to peroxides generated in the body due to aging, stress, chemical substances, etc. It is said that
[0006] Originally, as a biological function, excess peroxide is eliminated by the action of a peroxide-eliminating enzyme (superoxide dismutase) secreted in the body. However, deterioration of the global environment and unhealthy eating habits contribute to the generation of peroxides.
It is known that ingesting various minerals in a well-balanced manner activates body cells to suppress the generation of the above-mentioned peroxides, or acts directly to exhibit the same effect as an erasing enzyme. Therefore, many diseases occur when intake of minerals is insufficient or when absorption is inhibited and minerals are insufficient. Therefore, when the elderly actively take minerals from other than food, diseases such as adult diseases are prevented and improved.
In recent years, as a source of these ingested minerals, techniques and effects of composite minerals (hereinafter referred to as marine minerals) obtained by concentrating or drying and solidifying seawater pumped from the deep sea have been reported. For example, "Effects of seawater minerals on experimental diabetic mice" Japan Medical News No. 3675 (October 1994), "Therapeutic and / or preventive agent composed of marine mineral components" Patent Publication No. 3247620, "Water containing marine minerals" No. 2001-310192.
The inventor has studied the effects of marine minerals for many years and has also verified the above-described technique. As a result, it was found that marine minerals are extremely effective as a mineral intake source from the viewpoint of the balance of mineral components and economic viewpoint.
However, the present inventor has repeated many tests, and it has been found that about 40% of those who take marine minerals have a change in digestive function such as diarrhea and constipation. Therefore, in order to provide marine minerals as a safe and inexpensive source of minerals, it has been urgent to develop marine minerals that do not interfere with digestive function.
[0011]
[Problems to be solved by the invention]
The present invention is to provide a novel composition mainly composed of marine minerals. More specifically, it is intended to provide a novel marine mineral composition that is highly effective and efficient without causing any problems in digestive function.
[0012]
[Means for Solving the Problems]
The present inventor has made the present invention by studying the effects of natural minerals, particularly marine minerals obtained by concentrating and purifying deep sea water not containing unnecessary impurities for many years. The improved marine mineral of the present invention is achieved by a combination of at least one lactic acid bacterium and a syrup culture extract obtained by co-culturing one or more yeasts (hereinafter referred to as lactic acid bacterium co-culture extract). The
The marine mineral of the present invention will be described in detail. In recent years, the incidence of adult diseases such as heart disease, diabetes and malignant tumors is increasing. In the background, there is a biased eating habits such as heavy use of processed foods and insufficient intake of marine products. In addition, there is a state in which nutrients that should be absorbed by plants cannot be ingested from the soil due to excessive use of chemical fertilizers and pesticides due to the advancement of agricultural efficiency. This causes unbalanced nutrition intake, especially a chronic deficiency of minerals, and causes the balance of the living body to be lost.
As can be seen from the fact that all living organisms are generated from the sea, seawater contains all minerals in a well-balanced manner and is considered to be very close to the composition of human body fluids. In other words, it is extremely reasonable to take minerals from seawater, especially deep seawater without environmental pollution, and take it as a deficient mineral.
Accordingly, the marine mineral in the present invention is obtained from at least 100 m above the sea level, preferably from 250 m or less, and further obtained by removing excess sodium ions, organic mercury and cadmium compounds and concentrating to dryness.
The marine mineral according to the present invention is produced by the method described in Japanese Patent No. 3247620. That is to say, the volume capacity is reduced to about 1/60 from the pumped seawater by a concentration operation, and salt is removed. Further, 99% acetic acid and 0.5% by weight of charcoal are added to the concentrated solution, heated to 400 ° C. under pressure sealing, and further cooled to −12 ° C. By this operation, harmful metals such as mercury are deposited. Solid matter is removed by filtration operation, and the same superheated cooling treatment is repeated for the obtained filtrate, and the filtrate is concentrated to dryness to produce a desired solid powdery marine mineral. This manufacturing method is described as an example, and the present invention is not limited to this.
1 g of marine mineral obtained in this way is obtained from about 10 L of seawater. The composition of 1 g of marine minerals that have been announced is as follows.
Moisture 242,700μg
Sodium 54,300μg
Potassium 81,600μg
Calcium 310,600μg
Magnesium 1,700 μg
Organic 253,400μg
Chlorine 35,300 μg
125 μg of silicon
Iron 125μg
Copper 8μg
250μg of chromium
Manganese 10μg
Zinc 60μg
Selenium 16μg
Cadmium not detected Lead not detected Organic mercury Not detected lactic acid bacteria co-cultured extract related to the present invention refers to a produced extract produced by breeding and cultivating multiple types of lactic acid bacteria and yeast mainly using grains as nutrients and nutrients. .
More than 100 trillions of more than 100 types of intestinal microorganisms inhabit the human digestive organs, particularly in the intestines. As enteric bacteria, dozens of useful bacteria such as B. bacterium and Acidophilus are known.
The main functions of these useful bacteria are to help digestion and absorption, to synthesize vitamins, proteins and hormones, to prevent the propagation of pathogenic bacteria and to make bowel movements.
On the other hand, harmful bacteria that cause intestinal rot, produce harmful substances (indole, skatole, nitrosamine, hydrogen sulfide, ammonia, etc.) and harmful toxins inhabit the intestines.
Examples of harmful fungi include Welsh fungi, Escherichia coli, green-rich fungi, Bayonella fungi, staphylococci, and Proteus fungi.
In the human intestine, the useful bacteria and harmful bacteria described above are breeding in a balanced manner, producing secretions from each other and maintaining their own breeding environment. Therefore, it is easily understood that a favorable physical condition can be maintained if an environment in which useful bacteria easily grow in the intestine is provided or if useful bacteria are supplemented separately.
It is known that useful bacteria such as lactic acid bacteria are generally difficult to take orally. This is because lactic acid bacteria and the like die in a low PH range when passing through the stomach.
On the other hand, products produced by useful bacteria such as lactic acid bacteria do not die or decompose, so that they can easily reach the intestine and promote the growth of useful bacteria.
In many years of research, the present inventor has been able to ingest minerals efficiently and without affecting the digestive organs, by combining the lactic acid bacteria with yeast and adding the yeast to the cultivated cereal culture and the aforementioned marine minerals. I found out.
The lactic acid bacteria co-cultivated extract related to the present invention will be further described. Many techniques have been reported on lactic acid bacteria cultivated extract, and patent applications have been filed. For example, Japanese Patent Application Laid-Open No. 9-132533 “ulcer suppression effect and liver damage inhibitor comprising lactic acid bacteria fermented product”, Japanese Patent Application Laid-Open No. 9-289890 “Method for producing lactic acid bacteria dry powder”, Japanese Patent Application Laid-Open No. 10-210947, “Lactic acid bacteria” -Containing tofu, lactic acid bacteria-containing soy milk and fermented soy milk, and methods for producing them ", Japanese Patent Application Laid-Open No. 11-56302,“ Additional Use of Certain Oligosaccharides and Lactic Acid Bacteria Metabolites to Health Foods ”, Japanese Patent No. 2904879 Sensitive lactic acid bacteria mutant, fermented plant produced using the same, and method for producing the same, Japanese Patent Application Laid-Open No. 2000-300211, “Health food composition containing lactic acid bacteria metabolic product”, Japanese Patent Application Laid-Open No. 2001-224330, “Lactic acid bacteria” Foods composed of cultivated cultures and medicinal plants and production methods thereof, etc. It will be different, but can be applied to achieve the art.
Examples of the lactic acid machine used according to the present invention include Streptococcus thermophilus, Streptococcus cremolith, Streptococcus faecalis, Streptococcus lactis, Streptococcus bulgaricus, Lactobacillus andfilus, Lactobacillus casei, Lactobacillus terbrudsky, Lactobacillus arabinose, Lactobacillus caukaticus, Lactobacillus lactis, Lactobacillus raishmani, Lactobacillus mucus, Lactobacillus thermophilus, Lactobacillus blantalum, Lactobacillus vent Acetics, Lactobacillus euclity, Lactobacillus bulgaricus, Leuconostok mesendeleutes, Lactobacillus a Names such as Dophilus, Lactobacillus helibeticus, Lactobacillus fermentum, Lactobacillus bifidum, Lactobacillus bentacetics, Lactobacillus euclity, Lactobacillus bulgaricus, Lactobacillus korungchen, Micrococcus lactes I can do it. Preferably, 5 or more types of Lactobacillus fungi are used.
Examples of yeasts used in accordance with the present invention include Saccharomyces cerevisiae, Saccharomyces bastrianus, Saccharomyces intermedius, Saccharomyces validus, Saccharomyces ellipticus, Saccharomyces marilisla, Saccharomyces manschlicus, Saccharomyces saccharomyces Baker, Saccharomyces shearling, Saccharomyces biformis, Saccharomyces anamensis, Saccharomyces carteraginos, Saccharomyces awamori, Saccharomyces batatae, Saccharomyces coraneus, Saccharomyces romastros, Saccharomyces sarcosine Vinegar Rakutesu, Saccharomyces Mayor, can be mentioned Saccharomyces yeast such as Saccharomyces Rukushi. It is preferable to use two or more types of Saccharomyces yeast having good compatibility.
As the medium nutrient for co-culturing the above lactic acid bacteria and yeast, as plants, vegetables such as cucumber, radish, carrot, tomato, rice cake, Chinese cabbage, cabbage, potato, taro, sweet potato, long rice cake, etc. Grains such as potatoes, rice, wheat, straw, rice cake, sesame, corn, beans such as soybeans, red beans, green beans, broad beans, fruits such as apples, pears, strawberries, bananas, watermelons, peaches, ume, strawberries, grapes Fish, shellfish such as sama, sardine, horse mackerel, mackerel, squid, sea bream, clam, seaweed such as Amakusa, kelp, Aosa, green laver, meat and milk of animals such as cattle, horses, pigs, birds, sheep and rabbits Can be used. Particularly preferred medium nutrients include cereals. More preferred is a combination of beans and vegetables rich in fiber such as cabbage.
An example of a method for producing a lactic acid bacteria co-cultivated extract according to the present invention will be described. However, this example does not limit the present invention.
[0032]
(1) Preparation of seed mother Grains of cereals such as white rice and potatoes such as sweet potatoes are pulverized and adjusted to a solid content of 25% by adding water if necessary. Mix well. Add 10% by weight of turmeric powder to this cereal / potato slurry, add any 4 types of lactic acid bacteria and 2 types of yeast, stir for 30 minutes with a stirrer and leave at room temperature for 2 to 3 weeks. Add 3 times the amount of cold water to the fermented cereal / potato slurry once the liquid temperature has risen from 35 ° C to 40 ° C and then lowered to room temperature, and leave the supernatant in a low temperature room at 10 ° C or lower for 2 days. Take it away. The obtained slightly turbid liquid is heated with stirring at 70 ° C. for 30 minutes, and then stored in a refrigerator to obtain a lactic acid bacteria seed mother.
(2) Preparation of culture extract Soybeans (5 kg) were thoroughly washed with water and allowed to stand for a whole day to fully contain water. 20 L of a solution in which lactic acid bacteria seed mother / water is 1/3 is added thereto. Next, this is put into a paste using a mixer. This soybean paste containing lactic acid bacteria is heated at 105 ° C. for 15 minutes in an autoclave to sterilize miscellaneous bacteria. The sterilized soybean was cooled to 35 ° C. and subjected to lactic acid fermentation for 24 hours. Furthermore, this is left still for 3 months in a sealed state at room temperature kept at 8 ° C. or lower, and low temperature fermentation is continued. After completion of the fermentation, the solid matter is removed with a carbon filter and further heated in an autoclave at 121 ° C. for 20 minutes to sterilize all the microorganisms to obtain a lactic acid bacteria co-cultured extract.
The main components per 100 g of the obtained lactic acid bacteria co-cultured extract are shown below.
Sodium 23.8mg
Potassium 130.8mg
Calcium 25.0mg
Magnesium 31.4mg
Iron 0.5mg
Chlorine 50.2mg
Zinc 443 μg
Manganese 158 μg
Copper 17 μg
Sulfur 20.3mg
Vitamins 50 μg
Amino acids 25.7mg
The lactic acid bacterium co-cultivated extract of the present invention can be provided in a liquid form, a concentrated semi-liquid form, a powder form obtained by spray-drying the liquid, or a granular form or a tablet form using an excipient. In the present invention, it is preferable to use powder or granules.
The most preferred form of the present invention is more preferably one in which a lactic acid bacteria co-cultivated extract is included by branched dextrin or amylose.
The inclusion of the lactic acid bacterium co-cultured extract component and branched dextrin or amylose in the present invention is carried out by adding an equal amount of branched cyclodextrin (for example, Inelite P: manufactured by Nikken Chemical Co., Ltd.) to the cultured extract. Can be manufactured by spray drying after stirring for a minute.
The marine mineral and lactic acid bacteria co-cultivated extract of the present invention, preferably the solid marine mineral and solid lactic acid bacteria co-cultivated extract, can be used by simply mixing them together. Further, after mixing both, an excipient, a binder, a disintegrant, an anti-caking agent, a lubricant, a coating agent, and the like may be appropriately used and integrated.
The amount ratio of the solid marine mineral and the lactic acid bacterium co-cultured extract in the present invention is not particularly limited. A particularly preferred ratio is in the range of 0.1 to 10 parts by weight of the lactic acid cultivated cultivated extract with respect to 1 part by weight of the marine mineral.
[0039]
【Example】
The effects of the present invention will be described below in more detail as examples, but the present invention is not limited thereby.
[0040]
[Example 1] 0 g, 25 g, 50 g, 100 g, and 200 g of lactic acid bacteria co-cultured extract (Wide Planning Co., Ltd.) clathrated per 100 g of marine mineral (manufactured by Marine Science Research Institute) were mixed well in a mortar. Five levels of marine mineral / lactic acid bacteria co-culture extract composites were prepared. 75 healthy women in their 50s who are arbitrarily healthy are divided into 5 groups, and 5 kinds of lactic acid bacteria co-cultivation extract with different contents prepared for each 15 people. The dose was taken in 3 doses to reach 1.5 g. The following results were obtained by examining the state of diarrhea and constipation for 7 days.
Figure 2004018522
It can be seen that the combined use of the marine mineral and the lactic acid bacterium co-cultivated extract according to the present invention is extremely effective in reducing diarrhea or constipation symptoms caused by taking the marine mineral.
[0041]
[Example 2] Thirty people aged 40 to 70 who have hypertension and improved symptoms by taking marine neral and who have diarrhea or constipation symptoms. Was taken in three divided doses of 1.5 g of marine minerals per day. After one month, the patient continued to take for another 7 days, and diarrhea and constipation symptoms and systolic blood pressure were measured.
Result 1
25 people with improved diarrhea or constipation 3 people with no change in diarrhea or constipation 3 people with diarrhea or worse constipation 2 results 2
18 people whose systolic blood pressure decreased 10 mmHg or more 12 people who did not change their systolic blood pressure 12 people who had their systolic blood pressure increased 10 mmHg or more It can also be seen that the functional effects of marine minerals are also promoted.
[0042]
[Effects of the Invention] By taking a combination of marine minerals and lactic acid bacteria co-cultured extract, indigestion and symptoms such as diarrhea and constipation caused by marine minerals can be reduced, and the functional effect of marine minerals can be further increased. .

Claims (1)

少なくとも海水を濃縮し且つ不要成分を除去して得られる海洋ミネラルと、穀類を培養養分とし1種以上の乳酸菌及び酵母を作用させて得られる乳酸菌共棲培養エキスからなる、疾病予防及び治療組成物。A disease prevention and treatment composition comprising a marine mineral obtained by concentrating at least seawater and removing unnecessary components, and a lactic acid bacteria co-cultivated extract obtained by reacting one or more lactic acid bacteria and yeast with cereal as a culture nutrient.
JP2002213145A 2002-06-18 2002-06-18 Disease preventive and therapeutic formulation comprising sea mineral and lactobacillus symbiotic culture extract Pending JP2004018522A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002213145A JP2004018522A (en) 2002-06-18 2002-06-18 Disease preventive and therapeutic formulation comprising sea mineral and lactobacillus symbiotic culture extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002213145A JP2004018522A (en) 2002-06-18 2002-06-18 Disease preventive and therapeutic formulation comprising sea mineral and lactobacillus symbiotic culture extract

Publications (1)

Publication Number Publication Date
JP2004018522A true JP2004018522A (en) 2004-01-22

Family

ID=31184466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002213145A Pending JP2004018522A (en) 2002-06-18 2002-06-18 Disease preventive and therapeutic formulation comprising sea mineral and lactobacillus symbiotic culture extract

Country Status (1)

Country Link
JP (1) JP2004018522A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006230404A (en) * 2005-01-31 2006-09-07 Kirin Well Foods Co Ltd Food or drug comprising lactic acid bacterium containing mineral
KR102139024B1 (en) * 2020-02-24 2020-07-28 에스케이바이오랜드 주식회사 Lava seawater hydrophobic protein coating paraprobiotics manufacturing method and excellent lava seawater hydrophobic protein coating paraprobiotics or immune enhancing composition using the same method
WO2020204576A1 (en) * 2019-04-05 2020-10-08 에스케이바이오랜드 주식회사 Method for preparation of lava seawater-derived hydrophobic protein-coated paraprobiotics, lava seawater-derived hydrophobic protein-coated paraprobiotics having excellent immune activity prepared thereby, and immunostimulatory composition
WO2020204615A1 (en) * 2019-04-05 2020-10-08 에스케이바이오랜드 주식회사 Method for producing lava seawater-derived natural mineral-coated probiotics and lava seawater-derived natural mineral-coated probiotics using same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006230404A (en) * 2005-01-31 2006-09-07 Kirin Well Foods Co Ltd Food or drug comprising lactic acid bacterium containing mineral
WO2020204576A1 (en) * 2019-04-05 2020-10-08 에스케이바이오랜드 주식회사 Method for preparation of lava seawater-derived hydrophobic protein-coated paraprobiotics, lava seawater-derived hydrophobic protein-coated paraprobiotics having excellent immune activity prepared thereby, and immunostimulatory composition
WO2020204615A1 (en) * 2019-04-05 2020-10-08 에스케이바이오랜드 주식회사 Method for producing lava seawater-derived natural mineral-coated probiotics and lava seawater-derived natural mineral-coated probiotics using same
KR102139024B1 (en) * 2020-02-24 2020-07-28 에스케이바이오랜드 주식회사 Lava seawater hydrophobic protein coating paraprobiotics manufacturing method and excellent lava seawater hydrophobic protein coating paraprobiotics or immune enhancing composition using the same method

Similar Documents

Publication Publication Date Title
US6953574B2 (en) Method for producing a fermented hydrolyzed medium containing microorganisms
KR100899869B1 (en) Method of preparing powder kimchi and kimchi composition using the same
CN107259578A (en) A kind of probiotic composition and preparation method thereof
CN102885163B (en) Tuckahoe-flavored functional cheese cake and preparation method thereof
CN104770731A (en) Cynomorium songaricum ferment and preparation technology thereof
CN103271274B (en) Nutrient health-care porridge
CN109846035A (en) A kind of compound probiotic composition with body weight control
CN107751644A (en) Phase cray feed and preparation method thereof between shelling
CN106879902A (en) Barley seedling powder solid beverage with and preparation method thereof
CN105533671A (en) Preparation method of selenium-rich hericium erinaceus tablets
CN104664515B (en) A kind of blue berry miscellaneous grain crops fermented beverage and preparation method thereof
CN107439844A (en) A kind of Penaeus Vannmei special swelling feed
CN1254256A (en) Stabilized solid bacteria compositions
JP4762987B2 (en) Antihypertensive agent obtained by lactic acid bacteria culture
CN106954673A (en) A kind of dairy products comprising probiotics and preparation method thereof
JP2003210133A (en) Production and use of fermentation product
WO2014194707A1 (en) Calculus enzyme and preparation method therefor
CN112931866A (en) Edible amino acid enzyme and preparation method thereof
CN108850667A (en) A kind of microorganism Remixed agent
CN104430867A (en) Preparation method of living bacterium type red jujube acid milk beverage
CN107581429A (en) A kind of Chinese herbal medicine compound probiotic health beverages and preparation method thereof
JP2004018522A (en) Disease preventive and therapeutic formulation comprising sea mineral and lactobacillus symbiotic culture extract
JP2021534745A (en) Improved human food
CN106135427A (en) Lactic acid bacteria, vegetable protein beverage formula
CN104430852A (en) Preparation method of living bacterium type sweet orange acid milk beverage